Smarter Studies
We work to deliver swifter and more effective translation of scientific research into patient benefits
Global Impact
We are at the forefront of resolving internationally important questions
Better Health
Our research helps to improve healthcare around the world
The MRC Clinical Trials Unit at UCL became the UCL Innovative Clinical Trials Unit in April 2026. The Innovative Clinical Trials Unit is continuing the mission of smarter studies and global impact, leading to better health.
Latest News
AI tool for radiotherapy can support the global effort to eliminate cervical cancer
An AI technology is effective at planning the delivery of life-saving radiotherapy for cervical cancer and prostate cancer.
18 May
A routine blood test offers new insight into survival in advanced prostate cancer
Analysis from the STAMPEDE trial shows that combining a PSA blood test with information about cancer burden at diagnosis predicts survival more accurately than PSA levels alone.
30 Apr
Young people living with HIV should take their HIV medicines daily, according to the BREATHER+ trial
BREATHER+ results published in The Lancet HIV confirm that taking HIV medicines every day without breaks remains the best way to keep the virus under control.
08 Apr
Hormone patches are as effective as injections for treating non-metastatic prostate cancer
Evidence from the PATCH and STAMPEDE trial networks broadens treatment options for people with prostate cancer who are starting long-term hormone therapy.
26 Mar
In 2024, we celebrated our 25th anniversary. That's 25 years of smarter studies, global impact and better health. '25 at 25' is a series of articles highlighting 25 of our major achievements in that time.
Research Themes
Cancer
Innovative clinical trial design and meta-analysis extending beyond the boundaries of single cancer types
Infections
Major international clinical trials answering questions of global public health significance
Neurodegenerative diseases
New generation of innovative multi-arm multi-stage trials to identify and test new therapeutic treatments in neurodegenerative diseases (NDD)
Methodology
Development of methods with direct impact on the design, conduct and analysis of studies
Other Research & Policy
This section will capture projects outside the current QQR themes
